FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092237141> ?p ?o ?g. }

• W3092237141 abstract "Inadequate accuracy of ultrasound-guided core needle biopsy (US-CNB) urges further improvement for the diagnosis and management of lymphoma to meet with the practitioners' increased reliance on this mini-invasive approach.Data related to US-CNB of the deep-sited dominant lesions suspicious of lymphoma detected by computer tomography or positron-emission tomography/computer tomography for eligibility assessment of three prospective clinical trials were collected in advance. A retrospective analysis of the prospective data collection was performed, in which Viable-targeting US-CNB that Color Doppler flow imaging (CDFI) and/or contrast enhanced ultrasound (CEUS) were employed to select viable area for biopsy target compared with Routine US-CNB that routine procedure of evaluation and guidance using gray-scale ultrasound with CDFI in terms of the yield of clinically actionable diagnosis and safety, and determinants for the successful US-CNB that established an actionable diagnosis were explored. The establishment of final diagnosis was based on surgical pathology or medical response to therapy with follow-up at least 6 months.A total of 245 patients underwent Routine US-CNB (N = 120) or Viable-targeting US-CNB (N = 125), of which 91 (91/120, 75.8%) and 112 (112/125, 89.6%) were revealed with actionable diagnoses, respectively (p = 0.004, OR 0.846, 95% CI: 0.753-0.952). And 239 patients established final diagnoses. Diagnostic yields of actionable diagnosis according to the final diagnoses were 78.4% (91/116) and 91.1% (112/123) (p = 0.006, OR 0.554, 95% CI: 0.333-0.920), 82.6% (90/109) and 92.5% (111/120) for malignancy, 84.0% (84/100) and 91.8% (101/110) for lymphoma, 85.1% (80/94) and 92.3% (96/104) for Non-Hodgkin Lymphoma, 66.7% (4/6) and 83.3% (5/6) for Hodgkin Lymphoma in Routine and Viable-targeting CNB groups, respectively. No major complications were observed. Dominant lesions with actionable diagnosis in US-CNB were with higher FDG-avid Standardized Uptake Value. Binomial logistic regression revealed that actionable diagnosis of US-CNB was correlated with group and ancillary studies.Viable-Targeting US-CNB was superior to routine US-CNB in term of the yield of actionable diagnosis for deep-sited dominant lesions suspicious of lymphoma, which demonstrated a potential to be the initial approach in this setting." @default.
• W3092237141 created "2020-10-15" @default.
• W3092237141 creator A5014737817 @default.
• W3092237141 creator A5025904134 @default.
• W3092237141 creator A5029254825 @default.
• W3092237141 creator A5040210858 @default.
• W3092237141 creator A5047661456 @default.
• W3092237141 creator A5052883326 @default.
• W3092237141 creator A5061006889 @default.
• W3092237141 creator A5069921704 @default.
• W3092237141 creator A5079594267 @default.
• W3092237141 date "2020-10-07" @default.
• W3092237141 modified "2023-09-24" @default.
• W3092237141 title "Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma" @default.
• W3092237141 cites W1819812948 @default.
• W3092237141 cites W1824506103 @default.
• W3092237141 cites W1977168924 @default.
• W3092237141 cites W1996811206 @default.
• W3092237141 cites W2042582111 @default.
• W3092237141 cites W2051018444 @default.
• W3092237141 cites W2068389142 @default.
• W3092237141 cites W2071571902 @default.
• W3092237141 cites W2103307646 @default.
• W3092237141 cites W2108083659 @default.
• W3092237141 cites W2119147717 @default.
• W3092237141 cites W2131900456 @default.
• W3092237141 cites W2132758576 @default.
• W3092237141 cites W2140419795 @default.
• W3092237141 cites W2156653782 @default.
• W3092237141 cites W2158372243 @default.
• W3092237141 cites W2260597923 @default.
• W3092237141 cites W2272984102 @default.
• W3092237141 cites W2310716991 @default.
• W3092237141 cites W2398538696 @default.
• W3092237141 cites W2543485676 @default.
• W3092237141 cites W2583043639 @default.
• W3092237141 cites W2598700764 @default.
• W3092237141 cites W2749020974 @default.
• W3092237141 cites W2784694373 @default.
• W3092237141 cites W2793235304 @default.
• W3092237141 cites W2883860769 @default.
• W3092237141 cites W2911188335 @default.
• W3092237141 doi "https://doi.org/10.3389/fonc.2020.500153" @default.
• W3092237141 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7577120" @default.
• W3092237141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33117672" @default.
• W3092237141 hasPublicationYear "2020" @default.
• W3092237141 type Work @default.
• W3092237141 sameAs 3092237141 @default.
• W3092237141 citedByCount "5" @default.
• W3092237141 countsByYear W30922371412021 @default.
• W3092237141 countsByYear W30922371412022 @default.
• W3092237141 crossrefType "journal-article" @default.
• W3092237141 hasAuthorship W3092237141A5014737817 @default.
• W3092237141 hasAuthorship W3092237141A5025904134 @default.
• W3092237141 hasAuthorship W3092237141A5029254825 @default.
• W3092237141 hasAuthorship W3092237141A5040210858 @default.
• W3092237141 hasAuthorship W3092237141A5047661456 @default.
• W3092237141 hasAuthorship W3092237141A5052883326 @default.
• W3092237141 hasAuthorship W3092237141A5061006889 @default.
• W3092237141 hasAuthorship W3092237141A5069921704 @default.
• W3092237141 hasAuthorship W3092237141A5079594267 @default.
• W3092237141 hasBestOaLocation W30922371411 @default.
• W3092237141 hasConcept C126838900 @default.
• W3092237141 hasConcept C141071460 @default.
• W3092237141 hasConcept C142724271 @default.
• W3092237141 hasConcept C143753070 @default.
• W3092237141 hasConcept C188816634 @default.
• W3092237141 hasConcept C2775842073 @default.
• W3092237141 hasConcept C2775934546 @default.
• W3092237141 hasConcept C2779338263 @default.
• W3092237141 hasConcept C2779585989 @default.
• W3092237141 hasConcept C3019130837 @default.
• W3092237141 hasConcept C529618451 @default.
• W3092237141 hasConcept C534262118 @default.
• W3092237141 hasConcept C71924100 @default.
• W3092237141 hasConceptScore W3092237141C126838900 @default.
• W3092237141 hasConceptScore W3092237141C141071460 @default.
• W3092237141 hasConceptScore W3092237141C142724271 @default.
• W3092237141 hasConceptScore W3092237141C143753070 @default.
• W3092237141 hasConceptScore W3092237141C188816634 @default.
• W3092237141 hasConceptScore W3092237141C2775842073 @default.
• W3092237141 hasConceptScore W3092237141C2775934546 @default.
• W3092237141 hasConceptScore W3092237141C2779338263 @default.
• W3092237141 hasConceptScore W3092237141C2779585989 @default.
• W3092237141 hasConceptScore W3092237141C3019130837 @default.
• W3092237141 hasConceptScore W3092237141C529618451 @default.
• W3092237141 hasConceptScore W3092237141C534262118 @default.
• W3092237141 hasConceptScore W3092237141C71924100 @default.
• W3092237141 hasLocation W30922371411 @default.
• W3092237141 hasLocation W30922371412 @default.
• W3092237141 hasLocation W30922371413 @default.
• W3092237141 hasLocation W30922371414 @default.
• W3092237141 hasOpenAccess W3092237141 @default.
• W3092237141 hasPrimaryLocation W30922371411 @default.
• W3092237141 hasRelatedWork W2122946345 @default.
• W3092237141 hasRelatedWork W2343148945 @default.
• W3092237141 hasRelatedWork W2353856311 @default.
• W3092237141 hasRelatedWork W2392300227 @default.
• W3092237141 hasRelatedWork W2393861677 @default.
• W3092237141 hasRelatedWork W3002704560 @default.

• next